195 related articles for article (PubMed ID: 15698637)
21. Medaka fish Parkinson's disease model.
Matsui H; Gavinio R; Takahashi R
Exp Neurobiol; 2012 Sep; 21(3):94-100. PubMed ID: 23055787
[TBL] [Abstract][Full Text] [Related]
22. The Spatial Organization of the Intranuclear Structures of Human Brain Dopaminergic Neurons.
Korzhevskii DE; Gusel'nikova VV; Kirik OV; Sukhorukova EG; Grigorev IP
Acta Naturae; 2017; 9(3):81-88. PubMed ID: 29104779
[TBL] [Abstract][Full Text] [Related]
23. Design, Synthesis and In Vitro Evaluation of Levodopa Stearic Acid Hydrazide Conjugate for the Management of Parkinson's DiseaseNovel Conjugate for Parkinson's Disease.
Chinraj V; Reddy RA; Selvaraj J; Sureshkumar R
Drug Res (Stuttg); 2024 Feb; 74(2):60-66. PubMed ID: 38286420
[TBL] [Abstract][Full Text] [Related]
24. Dopamine Neuron Challenge Test for early detection of Parkinson's disease.
Zhou J; Li J; Papaneri AB; Kobzar NP; Cui G
NPJ Parkinsons Dis; 2021 Dec; 7(1):116. PubMed ID: 34916526
[TBL] [Abstract][Full Text] [Related]
25. Retraction Note: Dopaminergic Neuronal Death in Substantia Nigra Associates with Serum Levels of Total Bilirubin, Selenium, and Zinc: Evidences from 6-Hydroxydopamine Animal Model of Parkinson's Disease.
Sophiabadi M; Rastgoo N; Haghdoost-Yazdi H
Biol Trace Elem Res; 2024 May; ():. PubMed ID: 38809398
[No Abstract] [Full Text] [Related]
26. Plasminogen degrades α-synuclein, Tau and TDP-43 and decreases dopaminergic neurodegeneration in mouse models of Parkinson's disease.
Guo C; Wang T; Huang H; Wang X; Jiang Y; Li J
Sci Rep; 2024 Apr; 14(1):8581. PubMed ID: 38615036
[TBL] [Abstract][Full Text] [Related]
27. Brain-Derived Neurotrophic Factor (BDNF) in Mechanisms of Autistic-like Behavior in BTBR Mice: Crosstalk with the Dopaminergic Brain System.
Ilchibaeva T; Tsybko A; Lipnitskaya M; Eremin D; Milutinovich K; Naumenko V; Popova N
Biomedicines; 2023 May; 11(5):. PubMed ID: 37239153
[TBL] [Abstract][Full Text] [Related]
28. Embryoid Body Cells from Human Embryonic Stem Cells Overexpressing Dopaminergic Transcription Factors Survive and Initiate Neurogenesis via Neural Rosettes in the Substantia Nigra.
Ramos-Acevedo R; Morato-Torres CA; Padilla-Godínez FJ; Bernal-Conde LD; Palomero-Rivero M; Zafar F; Collazo-Navarrete O; Soto-Rojas LO; Schüle B; Guerra-Crespo M
Brain Sci; 2023 Feb; 13(2):. PubMed ID: 36831872
[TBL] [Abstract][Full Text] [Related]
29. New Frontiers in Neurodegeneration and Regeneration Associated with Brain-Derived Neurotrophic Factor and the rs6265 Single Nucleotide Polymorphism.
Szarowicz CA; Steece-Collier K; Caulfield ME
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887357
[TBL] [Abstract][Full Text] [Related]
30. Epigenetic Biomarkers as Diagnostic Tools for Neurodegenerative Disorders.
Martínez-Iglesias O; Naidoo V; Cacabelos N; Cacabelos R
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008438
[TBL] [Abstract][Full Text] [Related]
31. The Pleiotropic Potential of BDNF beyond Neurons: Implication for a Healthy Mind in a Healthy Body.
Di Rosa MC; Zimbone S; Saab MW; Tomasello MF
Life (Basel); 2021 Nov; 11(11):. PubMed ID: 34833132
[TBL] [Abstract][Full Text] [Related]
32. Serum mBDNF and ProBDNF Expression Levels as Diagnosis Clue for Early Stage Parkinson's Disease.
Yi X; Yang Y; Zhao Z; Xu M; Zhang Y; Sheng Y; Tian J; Xu Z
Front Neurol; 2021; 12():680765. PubMed ID: 34456846
[TBL] [Abstract][Full Text] [Related]
33. Brain-derived neurotrophic factor attenuates cognitive impairment and motor deficits in a mouse model of Parkinson's disease.
Chang E; Wang J
Brain Behav; 2021 Aug; 11(8):e2251. PubMed ID: 34132500
[TBL] [Abstract][Full Text] [Related]
34. Unfolding the Role of BDNF as a Biomarker for Treatment of Depression.
Rana T; Behl T; Sehgal A; Srivastava P; Bungau S
J Mol Neurosci; 2021 Oct; 71(10):2008-2021. PubMed ID: 33230708
[TBL] [Abstract][Full Text] [Related]
35. Psychological distress and lack of PINK1 promote bioenergetics alterations in peripheral blood mononuclear cells.
Grigoruţă M; Dagda RK; Díaz-Sánchez ÁG; Martínez-Martínez A
Sci Rep; 2020 Jun; 10(1):9820. PubMed ID: 32555260
[TBL] [Abstract][Full Text] [Related]
36. BDNF as a Promising Therapeutic Agent in Parkinson's Disease.
Palasz E; Wysocka A; Gasiorowska A; Chalimoniuk M; Niewiadomski W; Niewiadomska G
Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32050617
[TBL] [Abstract][Full Text] [Related]
37. PABPC1-induced stabilization of BDNF-AS inhibits malignant progression of glioblastoma cells through STAU1-mediated decay.
Su R; Ma J; Zheng J; Liu X; Liu Y; Ruan X; Shen S; Yang C; Wang D; Cai H; Li Z; Xue Y
Cell Death Dis; 2020 Feb; 11(2):81. PubMed ID: 32015336
[TBL] [Abstract][Full Text] [Related]
38. Activation of BDNF-AS/ADAR/p53 Positive Feedback Loop Inhibits Glioblastoma Cell Proliferation.
Lv X; Gu C; Guo S
Neurochem Res; 2020 Feb; 45(2):508-518. PubMed ID: 31939089
[TBL] [Abstract][Full Text] [Related]
39. Orexin-A Exerts Neuroprotective Effects via OX1R in Parkinson's Disease.
Liu MF; Xue Y; Liu C; Liu YH; Diao HL; Wang Y; Pan YP; Chen L
Front Neurosci; 2018; 12():835. PubMed ID: 30524223
[TBL] [Abstract][Full Text] [Related]
40. Genetic deletion of vesicular glutamate transporter in dopamine neurons increases vulnerability to MPTP-induced neurotoxicity in mice.
Shen H; Marino RAM; McDevitt RA; Bi GH; Chen K; Madeo G; Lee PT; Liang Y; De Biase LM; Su TP; Xi ZX; Bonci A
Proc Natl Acad Sci U S A; 2018 Dec; 115(49):E11532-E11541. PubMed ID: 30442663
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
